KB Securities Launches Wrap Product Investing in Blockchain and US Biotech

[Asia Economy Reporter Minwoo Lee] KB Securities is launching wrap account products that invest in blockchain and U.S. biotech companies.

On the 17th, KB Securities announced the launch of two themed wrap account services: 'KB Headquarters Customized - Blockchain Economy Wrap' and 'KB Headquarters Customized - Ieum Bio Wrap.'

These products were prepared to provide investment opportunities in the blockchain industry, which has a low correlation with traditional assets such as stocks, bonds, and commodities and is expected to diversify portfolios when invested alongside traditional assets, as well as the global healthcare industry, which has long-term growth potential.

'KB Headquarters Customized - Blockchain Economy Wrap' is managed based on advice from Plain Vanilla Investment Advisory, primarily investing in blockchain-related domestic and international listed stocks and exchange-traded funds (ETFs). The minimum subscription amount is 10 million KRW, and the contract period is one year.

'KB Headquarters Customized - Ieum Bio Wrap' is managed based on advice from Ieum Bio Lab, primarily investing in biotech stocks and ETFs listed on the U.S. Nasdaq market. The minimum subscription amount is 30 million KRW, and the contract period is one year.

Both products carry the risk of principal loss depending on investment results. 'KB Headquarters Customized - Blockchain Economy Wrap' charges a 1.5% annual deferred fee, while 'KB Headquarters Customized - Ieum Bio Wrap' charges a 1.0% upfront fee and a 1.6% annual deferred fee. These products can be subscribed to through KB Securities branches nationwide. For detailed information, please contact the branches or customer center.

Jung Kyunghoon, head of the wrap management department at KB Securities, said, "We plan to continuously strive to launch services that can be helpful to our customers."

This content was produced with the assistance of AI translation services.